Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 63Colonic Neoplasms 29Rectal Neoplasms 25Neoplasm Metastasis 11Stomach Neoplasms 8Carcinoma, Hepatocellular 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Liver Neoplasms 3Ovarian Neoplasms 2Esophageal Squamous Cell Carcinoma 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Peritoneal Neoplasms 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Melanoma 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gastrointestinal Neoplasms 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Gemcitabine 27Fluorouracil 25Oxaliplatin 21Cisplatin 19Leucovorin 17Bevacizumab 15130-nm albumin-bound paclitaxel 13Docetaxel 12Capecitabine 12Albumin-Bound Paclitaxel 12Paclitaxel 11Irinotecan 10Carboplatin 9pembrolizumab 7Radiotherapy 6Pemetrexed 6Nivolumab 6Erlotinib Hydrochloride 6Cyclophosphamide 6Trastuzumab 5Ramucirumab 5Ipilimumab 4Everolimus 4Crizotinib 4Cetuximab 4vandetanib 3trastuzumab deruxtecan 3sargramostim 3folfirinox 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma × Folfox protocol × Clear all
NCT02195180 2018-07-27

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

ERYtech Pharma

Phase 2 Completed
141 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡